ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Griesmer To Leave NTP, Will Return To Oak Ridge

March 28, 1980

In Brief: Reagan Names David Korn New Chairman Of NCAB; Consensus Conference On Limb Sparing Planned

June 22, 1984

Tumor Classification, Monoclonal Antibody Announcements Made

January 7, 1983

USDA Expands Role In 5 A Day Partnership

April 26, 2002

Survival Of Control Programs After NCI Money Runs Out Developing Into A Worrisome Issue

June 1, 1975

Pretreatment with Azacitidine Achieves 28-Month Remission

August 30, 2013